IDenta Corp. Releases March Sales Progress Report -- 10 Countries Listed in Company's Bid to Continue Industry

JERUSALEM, Mar 31 (MARKET WIRE) --
IDenta Corp. (PINKSHEETS: IDTA) released a report this morning listing some of
the countries where the company is currently selling products or in
negotiations.
IDenta Alert explosive detectors as well as IDenta Stinger & Confirm drug
detectors are listed in the report.

Yaacov Shoham, IDTA CEO, said, "This briefing covers activities which have
occurred in the past ten days. Orders for all of our products are coming
infrom around the globe, and a number of crucial negotiations are nearing
completion which will extend our customer base to an even greater international
presence. In the coming months we expect these orders to increase both in
number and in size. Our operations are fully prepared and capable of
delivering large orders of any of our products to anywhere in the world."

The following activities were listed in the briefing:

1. Canada -- Received an order from the government for explosive identifiers
to be
used by the Canadian army in Afghanistan. This order was procured by Crime
Sciences Inc., the company's representatives in Canada.

2. France -- Received a large order for drug detectors from the national
police
district in Versailles. IDenta is expecting to eventually receive orders from
all
the national police districts in France. French government officials have also
requested that IDenta investigate the development of a completely new type
of drug detection product.

3. United Kingdom -- Received an order for drug detectors from TestNow, LTD.
to be
sold in the retail market.

4. United States -- The company is very pleased with the progress that
JantPharmacal-Accutest, www.accutest.net, is making through its national network
of
representatives. Accutest is receiving new introductory orders from the field
each week and is expecting to begin receiving large orders starting June 2008.

Executives from Jant Pharmacal-Accutest are also responsible for the
placement of IDenta drug detection products with Galls, a leading international
resource for homeland security products, public safety equipment and
professional apparel, and a subsidiary of ARAMARK Corporation. A large order
for
IDenta drug detectors has already been received and IDenta expects these
orders to increase as distribution of the company's catalog and website
presence becomes known to thousands of Gall customers. Discussions are also
underway to include the IDenta Alert explosive identifiers in their catalog and
on the website also. See:
http://galls.com/style.HTML?assort=general_catalog&style=LE902.

5. Australia -- Shipped a large order of IDenta Bullet Hole Detectors.

6. Israel -- Delivered an order of IDenta drug detectors for the Israeli
Police.

7. Denmark, Sweden, Holland and Belgium -- A trade mission has been
scheduled
for late April for meetings that have been set with governmental decision makers
in
these countries.

8. Africa -- IBTEC, the company's representatives responsible for
procuringthe French government, is in final negotiations with several countries
in
West Africa with French alliances to begin supplying drug detectors in
thisvulnerable drug trafficking route to Europe.

9. Russia -- Started the registration process of IDenta drug and explosive
detectors.

10. Germany -- Submitted a bid for a large order of drug detectors to be
used in a local police department.

"Our mission is clear," declared Shoham. "To become the leading developer
and
supplier of proprietary on-site chemically based drug and explosive detectors."

About IDenta

Since 2003, IDenta Corporation has become recognized as a worldwide leader
in
the development of proprietary on-site drug and explosive detection kits. IDenta
develops, manufactures and distributes products for the both professional and
civil markets that consistently pass the highest qualifications and testing
procedures of law enforcement and security agencies around the world.
Information
concerning IDenta's entire product line may be found at www.IDenta.biz.

Disclaimer

Certain of the statements contained herein may be, within the meaning of the
federal securities laws, "forward-looking statements" that are subject to risks
and uncertainties that could cause actual results to differ materially from
those described in the forward-looking statements. Such forward-looking
statements involve known and unknown risks, uncertainties and other factors
which may
cause the actual results, performance or achievements of the company to be
materially different from any future results, performance or achievements
expressed or implied by such forward-looking statements. These forward-looking
statements are based on management's expectations as of the date hereof, and
the company does not undertake any responsibility to update any of these
statements in the future.

Contact:
For Investor Relations, lobbying interests or information concerning
IDenta's products internationally, contact:
Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487
fpi@drugsdetector.com

For Investor Relations in the US, contact:
Randy Jacobs
Corporate Spokesman
IDentaNews@sitcomllc.com
1-800-316-9437

For information about the Accutest(R) -- IDenta products in the US, please
contact:
Mr. Eyal Golan
COO
JANT PHARMACAL CORPORATION
16255 Ventura Blvd. #505
Encino, CA 91436
Toll Free: 800-676-5565
http://www.accutest.net

Copyright 2008, Market Wire, All rights reserved.

-0-